A Phase I trial of talazoparib in patients with advanced hematologic malignancies
Authors
Gopal, A. K.Popat, R.
Mattison, R. J.
Menne, T.
Bloor, Adrian
Gaymes, T.
Khwaja, A.
Juckett, M.
Chen, Y.
Cotter, M. J.
Mufti, G. J.
Affiliation
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USAIssue Date
2021
Metadata
Show full item recordCitation
Gopal AK, Popat R, Mattison RJ, Menne T, Bloor A, Gaymes T, et al. A Phase I trial of talazoparib in patients with advanced hematologic malignancies. Int J Hematol Oncol. 2021;10(3):Ijh35.Journal
International Journal of Hematologic OncologyDOI
10.2217/ijh-2021-0004PubMed ID
34840720Type
Articleae974a485f413a2113503eed53cd6c53
10.2217/ijh-2021-0004
Scopus Count
Collections
Related articles
- Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
- Authors: Naito Y, Kuboki Y, Ikeda M, Harano K, Matsubara N, Toyoizumi S, Mori Y, Hori N, Nagasawa T, Kogawa T
- Issue date: 2021 Dec
- Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers.
- Authors: de Bono J, Ramanathan RK, Mina L, Chugh R, Glaspy J, Rafii S, Kaye S, Sachdev J, Heymach J, Smith DC, Henshaw JW, Herriott A, Patterson M, Curtin NJ, Byers LA, Wainberg ZA
- Issue date: 2017 Jun
- Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors.
- Authors: Dhawan MS, Bartelink IH, Aggarwal RR, Leng J, Zhang JZ, Pawlowska N, Terranova-Barberio M, Grabowsky JA, Gewitz A, Chien AJ, Moasser M, Kelley RK, Maktabi T, Thomas S, Munster PN
- Issue date: 2017 Nov 1
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
- Authors: Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, Fehrenbacher L, Yerushalmi R, Mina LA, Martin M, Roché H, Im YH, Quek RGW, Markova D, Tudor IC, Hannah AL, Eiermann W, Blum JL
- Issue date: 2018 Aug 23
- Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.
- Authors: Wainberg ZA, Singh AS, Konecny GE, McCann KE, Hecht JR, Goldman J, Chmielowski B, Finn RS, O'Brien N, Von Euw E, Price MM, Martinez D, Yonemoto L, Brennan M, Glaspy JA, Slamon DJ
- Issue date: 2023 Jan 4